Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
US |
|
Galapagos NV
AEX:GLPG
|
BE |
|
R
|
Revo Insurance SpA
MIL:REVO
|
IT |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
US |
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
Grupo Aeroportuario del Centro Norte SAB de CV
BMV:OMAB
|
MX |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
E
|
Eimskipafelag Islands hf
ICEX:EIM
|
IS |
|
E
|
Ekachai Medical Care PCL
SET:EKH
|
TH |
Wall St Price Targets
AMLX Price Targets Summary
Amylyx Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AMLX is 23.87 USD with a low forecast of 19.19 USD and a high forecast of 35.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AMLX's stock price target?
Price Target
23.87
USD
According to Wall Street analysts, the average 1-year price target for
AMLX is 23.87 USD with a low forecast of 19.19 USD and a high forecast of 35.7 USD.